L: Antineoplastic and immunomodulating agents
| Level 2 code | Description |
|---|---|
| L01 | Antineoplastic agents |
| L02 | Endocrine therapy |
| L03 | Immunostimulants |
| L04 | Immunosuppressants |
Immunotherapy
CAR-T cell therapy
Chimeric Antigen Receptor (CAR T) cell therapy
Emily was the first patient with incurable leukemia, cured using CAR T therapy. Grupp et al., N Engl J Med 2013. https://www.nejm.org/doi/full/10.1056/nejmoa1215134
